Quantifying Potential Cost-Savings Through an Alternative Imaging-Based Diagnostic Process in Presumptive Seronegative Rheumatoid Arthritis

Pedro Santos-Moreno, Nelson J Alvis-Zakzuk, Edwin Castillo, Laura Villarreal, Carlos Pineda, Hugo Sandoval, Omaira Valencia

Open source

DOI
10.2147/ceor.s302404
Published
2021-06
Container
ClinicoEconomics and Outcomes Research
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ceor.s302404,
  title = {Quantifying Potential Cost-Savings Through an Alternative Imaging-Based Diagnostic Process in Presumptive Seronegative Rheumatoid Arthritis},
  author = {Pedro Santos-Moreno and Nelson J Alvis-Zakzuk and Edwin Castillo and Laura Villarreal and Carlos Pineda and Hugo Sandoval and Omaira Valencia},
  year = {2021},
  journal = {ClinicoEconomics and Outcomes Research},
  doi = {10.2147/ceor.s302404},
  url = {https://doi.org/10.2147/ceor.s302404}
}

RIS

TY  - JOUR
TI  - Quantifying Potential Cost-Savings Through an Alternative Imaging-Based Diagnostic Process in Presumptive Seronegative Rheumatoid Arthritis
AU  - Pedro Santos-Moreno
AU  - Nelson J Alvis-Zakzuk
AU  - Edwin Castillo
AU  - Laura Villarreal
AU  - Carlos Pineda
AU  - Hugo Sandoval
AU  - Omaira Valencia
PY  - 2021
JO  - ClinicoEconomics and Outcomes Research
DO  - 10.2147/ceor.s302404
UR  - https://doi.org/10.2147/ceor.s302404
ER  - 

APA

Santos-Moreno, P., Alvis-Zakzuk, N. J., Castillo, E., Villarreal, L., Pineda, C., Sandoval, H., & Valencia, O. (2021). Quantifying Potential Cost-Savings Through an Alternative Imaging-Based Diagnostic Process in Presumptive Seronegative Rheumatoid Arthritis. ClinicoEconomics and Outcomes Research. https://doi.org/10.2147/ceor.s302404

Source records